![Ana de Cos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Ana is an Associate in the Client Solutions team, having joined the infrastructure team as an Analyst in 2017.
Prior to Altamar, she gained experience working at the law firm CMS Albiñana & Suárez de Lezo (Madrid) and at the global technology and media travel company Big Worldwide (London).
Ana holds a Double Degree in Business Administration and Law from Universidad Autónoma de Madrid.
Precedenti posizioni note di Ana de Cos
| Società | Posizione | Fine |
|---|---|---|
Altamar Private Equity SGIIC SA /Private Equity/
 Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity invests in companies located across the globe. The firm targets businesses operating in the life sciences sector including biotechnology, infrastructure, medical devices, diagnostics, genomics, and digital health. It provides equity and debt financing for buyouts, secondary, special situations, and early to growth stage capital requirements. It also makes co-investments. | Analista di Private Equity | 01/01/2021 |
Formazione di Ana de Cos
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
66
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Colegio Universitario de Estudios Financieros
 Colegio Universitario de Estudios Financieros Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altamar Private Equity SGIIC SA /Private Equity/
Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity invests in companies located across the globe. The firm targets businesses operating in the life sciences sector including biotechnology, infrastructure, medical devices, diagnostics, genomics, and digital health. It provides equity and debt financing for buyouts, secondary, special situations, and early to growth stage capital requirements. It also makes co-investments. | Finance |
